日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 3,580 | 3,584 | 3,471 | 3,504 | -76 | -2.1% | 242,400 |
| 2025/04/03 | 3,584 | 3,610 | 3,546 | 3,580 | -101 | -2.7% | 238,000 |
| 2025/04/02 | 3,750 | 3,759 | 3,672 | 3,681 | -79 | -2.1% | 227,700 |
| 2025/04/01 | 3,817 | 3,831 | 3,751 | 3,760 | -42 | -1.1% | 276,400 |
| 2025/03/31 | 3,874 | 3,874 | 3,776 | 3,802 | -124 | -3.2% | 336,300 |
| 2025/03/28 | 3,943 | 3,956 | 3,901 | 3,926 | -96 | -2.4% | 166,500 |
| 2025/03/27 | 3,990 | 4,022 | 3,960 | 4,022 | +47 | +1.2% | 170,600 |
| 2025/03/26 | 4,000 | 4,027 | 3,971 | 3,975 | -54 | -1.3% | 232,300 |
| 2025/03/25 | 4,000 | 4,029 | 3,961 | 4,029 | +49 | +1.2% | 198,900 |
| 2025/03/24 | 4,033 | 4,033 | 3,975 | 3,980 | -55 | -1.4% | 123,100 |
| 2025/03/21 | 4,066 | 4,077 | 4,020 | 4,035 | -37 | -0.9% | 290,600 |
| 2025/03/19 | 4,087 | 4,170 | 4,041 | 4,072 | +43 | +1.1% | 220,900 |
| 2025/03/18 | 4,021 | 4,051 | 4,004 | 4,029 | +29 | +0.7% | 154,400 |
| 2025/03/17 | 3,969 | 4,007 | 3,969 | 4,000 | +34 | +0.9% | 108,500 |
| 2025/03/14 | 3,971 | 4,000 | 3,942 | 3,966 | -25 | -0.6% | 204,100 |
| 2025/03/13 | 3,999 | 4,054 | 3,969 | 3,991 | -14 | -0.3% | 164,200 |
| 2025/03/12 | 3,895 | 4,023 | 3,894 | 4,005 | +58 | +1.5% | 212,900 |
| 2025/03/11 | 3,946 | 3,974 | 3,858 | 3,947 | -39 | -1% | 304,900 |
| 2025/03/10 | 4,010 | 4,032 | 3,958 | 3,986 | -8 | -0.2% | 170,800 |
| 2025/03/07 | 3,985 | 3,996 | 3,951 | 3,994 | -16 | -0.4% | 183,500 |
| 2025/03/06 | 4,000 | 4,058 | 3,986 | 4,010 | +6 | +0.1% | 178,700 |
| 2025/03/05 | 4,096 | 4,096 | 3,993 | 4,004 | -72 | -1.8% | 259,600 |
| 2025/03/04 | 4,119 | 4,182 | 4,060 | 4,076 | -3 | -0.1% | 384,800 |
| 2025/03/03 | 3,985 | 4,096 | 3,949 | 4,079 | +141 | +3.6% | 340,400 |
| 2025/02/28 | 3,929 | 4,011 | 3,929 | 3,938 | +11 | +0.3% | 332,500 |
| 2025/02/27 | 3,919 | 3,951 | 3,893 | 3,927 | -2 | -0.1% | 236,300 |
| 2025/02/26 | 4,001 | 4,020 | 3,881 | 3,929 | -76 | -1.9% | 274,600 |
| 2025/02/25 | 3,873 | 4,023 | 3,872 | 4,005 | +132 | +3.4% | 372,500 |
| 2025/02/21 | 3,876 | 3,908 | 3,856 | 3,873 | +22 | +0.6% | 160,500 |
| 2025/02/20 | 3,905 | 3,942 | 3,830 | 3,851 | -64 | -1.6% | 172,300 |
| 2025/02/19 | 3,930 | 3,959 | 3,906 | 3,915 | -16 | -0.4% | 193,100 |
| 2025/02/18 | 3,890 | 3,957 | 3,890 | 3,931 | +25 | +0.6% | 139,700 |
| 2025/02/17 | 4,009 | 4,014 | 3,894 | 3,906 | -122 | -3% | 258,200 |
| 2025/02/14 | 3,920 | 4,028 | 3,900 | 4,028 | +66 | +1.7% | 277,900 |
| 2025/02/13 | 3,915 | 3,980 | 3,891 | 3,962 | +74 | +1.9% | 231,700 |
| 2025/02/12 | 3,934 | 3,983 | 3,864 | 3,888 | -70 | -1.8% | 357,600 |
| 2025/02/10 | 4,000 | 4,053 | 3,871 | 3,958 | +61 | +1.6% | 496,600 |
| 2025/02/07 | 3,882 | 4,016 | 3,868 | 3,897 | -3 | -0.1% | 341,900 |
| 2025/02/06 | 3,889 | 3,914 | 3,861 | 3,900 | +47 | +1.2% | 182,600 |
| 2025/02/05 | 3,800 | 3,873 | 3,787 | 3,853 | +39 | +1% | 191,500 |
| 2025/02/04 | 3,775 | 3,879 | 3,759 | 3,814 | +125 | +3.4% | 358,400 |
| 2025/02/03 | 3,759 | 3,775 | 3,640 | 3,689 | -76 | -2% | 372,400 |
| 2025/01/31 | 3,773 | 3,777 | 3,737 | 3,765 | -7 | -0.2% | 241,200 |
| 2025/01/30 | 3,705 | 3,795 | 3,705 | 3,772 | +72 | +1.9% | 286,600 |
| 2025/01/29 | 3,730 | 3,740 | 3,669 | 3,700 | -41 | -1.1% | 328,100 |
| 2025/01/28 | 3,808 | 3,832 | 3,727 | 3,741 | -54 | -1.4% | 266,000 |
| 2025/01/27 | 3,807 | 3,826 | 3,779 | 3,795 | +4 | +0.1% | 192,800 |
| 2025/01/24 | 3,762 | 3,857 | 3,762 | 3,791 | +22 | +0.6% | 275,100 |
| 2025/01/23 | 3,729 | 3,803 | 3,729 | 3,769 | +6 | +0.2% | 254,900 |
| 2025/01/22 | 3,769 | 3,789 | 3,749 | 3,763 | +15 | +0.4% | 161,300 |
1～
50
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +7.9% | +8.9% | 3.54% | 7.50倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 193,900円 | +5.0% | +1.5% | 0.00% | 16.65倍 | 4.43倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 62,100円 | +21.1% | - | 0.00% | 15.42倍 | 2.16倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
